Discover a recent study that found that microultrasonography-guided biopsy could provide an alternative to MRI.

A new study from Sunnybrook Health Sciences Centre and the University of Toronto has shown that high-resolution ultrasound is ...

A UK study found that using a polygenic risk score to identify men at highest genetic risk of prostate cancer significantly improved detection of clinically important disease. This approach caught ...

Of these 745 participants, 468 (62.8%) underwent MRI and prostate biopsy; prostate cancer was detected in 187 participants (40.0%). The median age at diagnosis was 64 years (range, 57 to 73).

Lara Rodriguez Sanchez, Samir Taneja, Hashim Ahmed, Himanshu Nagar, Edward Schaeffer in a Crossfire: Controversies in Urology debate: discussed if Focal Therapy is a Suitable Option for all Cases with ...

What changed his mind? ‘Data in the last decade with MRI scans shows that they are highly accurate at detecting the size and grade of prostate tumours.’ Now he’d recommend that SOME men ...

A biomarker, PROSTOX, predicted late genitourinary toxicity accurately in patients with prostate cancer, yielding an area under the curve of 0.76.

Diagnostic imaging is a critical process in identifying cancerous areas and informing treatment decisions for prostate cancer, which is the one of the most commonly diagnosed cancers in UK men ...

“Building on decades of research into the genetic markers of prostate cancer, our study shows that the theory does work in practice – we can identify men at risk of aggressive cancers who need further ...

The UK Medicines and Healthcare products Regulatory Agency (MHRA) has granted approval for trofolastat (RoTecPSMA), a prostate-specific membrane antigen (PSMA)-targeting agent for detecting ...